Found: 139
Select item for more details and to access through your institution.
Analysis of schizophrenia‐associated genetic markers in the HLA region as risk factors for tardive dyskinesia.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2024, v. 39, n. 4, p. 1, doi. 10.1002/hup.2898
- By:
- Publication type:
- Article
Awareness of illness moderates self-assessment of psychotic symptoms.
- Published in:
- Australian & New Zealand Journal of Psychiatry, 2022, v. 56, n. 10, p. 1287, doi. 10.1177/00048674211057480
- By:
- Publication type:
- Article
Role of advanced glycation end products in the longitudinal association between muscular strength and psychotic symptoms among adolescents.
- Published in:
- Schizophrenia (2754-6993), 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41537-022-00249-5
- By:
- Publication type:
- Article
Schizophrenia risk loci from xMHC region were associated with antipsychotic response in chronic schizophrenic patients with persistent positive symptom.
- Published in:
- Translational Psychiatry, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41398-022-01854-9
- By:
- Publication type:
- Article
Schizophrenia‐associated gene dysbindin‐1 and tardive dyskinesia.
- Published in:
- Drug Development Research, 2021, v. 82, n. 5, p. 678, doi. 10.1002/ddr.21681
- By:
- Publication type:
- Article
Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00591
- By:
- Publication type:
- Article
Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain.
- Published in:
- Journal of Neural Transmission, 2019, v. 126, n. 1, p. 27, doi. 10.1007/s00702-018-1921-1
- By:
- Publication type:
- Article
5-HT<sub>1A</sub> parital agonism and 5-HT<sub>7</sub> antagonism restore episodic memory in subchronic phencyclidine-treated mice: role of brain glutamate, dopamine, acetylcholine and GABA.
- Published in:
- Psychopharmacology, 2018, v. 235, n. 10, p. 2795, doi. 10.1007/s00213-018-4972-y
- By:
- Publication type:
- Article
A within‐subject consideration of the psychotic spectrum disorder concept in a patient in remission associated with cortical gray matter recovery.
- Published in:
- CNS Neuroscience & Therapeutics, 2018, v. 24, n. 7, p. 641, doi. 10.1111/cns.12986
- By:
- Publication type:
- Article
Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain.
- Published in:
- Neuropsychobiology, 2017, v. 74, n. 3, p. 169, doi. 10.1159/000457903
- By:
- Publication type:
- Article
Dopamine D<sub>4</sub> receptor stimulation contributes to novel object recognition: Relevance to cognitive impairment in schizophrenia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
GSK-3 β Interacts with Dopamine D1 Receptor to Regulate Receptor Function: Implication for Prefrontal Cortical D1 Receptor Dysfunction in Schizophrenia.
- Published in:
- CNS Neuroscience & Therapeutics, 2017, v. 23, n. 2, p. 174, doi. 10.1111/cns.12664
- By:
- Publication type:
- Article
Association study between the neurexin-1 gene and tardive dyskinesia.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2017, v. 32, n. 1, p. n/a, doi. 10.1002/hup.2568
- By:
- Publication type:
- Article
Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis.
- Published in:
- International Journal of Neuropsychopharmacology, 2016, v. 19, n. 5, p. 1, doi. 10.1093/ijnp/pyv132
- By:
- Publication type:
- Article
Genetic association analysis of N-methyl- d-aspartate receptor subunit gene GRIN2B and clinical response to clozapine.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 2, p. 121, doi. 10.1002/hup.2519
- By:
- Publication type:
- Article
The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia.
- Published in:
- Bipolar Disorders, 2015, v. 17, n. 5, p. 528, doi. 10.1111/bdi.12294
- By:
- Publication type:
- Article
Enantioselective Syntheses of Heteroyohimbine Natural Products: A Unified Approach through Cooperative Catalysis.
- Published in:
- Angewandte Chemie, 2015, v. 127, n. 23, p. 7004, doi. 10.1002/ange.201502011
- By:
- Publication type:
- Article
Enantioselective Syntheses of Heteroyohimbine Natural Products: A Unified Approach through Cooperative Catalysis.
- Published in:
- Angewandte Chemie International Edition, 2015, v. 54, n. 23, p. 6900, doi. 10.1002/anie.201502011
- By:
- Publication type:
- Article
Involvement of Cholinergic System in Hyperactivity in Dopamine-Deficient Mice.
- Published in:
- Neuropsychopharmacology, 2015, v. 40, n. 5, p. 1141, doi. 10.1038/npp.2014.295
- By:
- Publication type:
- Article
A Mouse Model of Human Primitive Neuroectodermal Tumors Resulting from Microenvironmentally-Driven Malignant Transformation of Orthotopically Transplanted Radial Glial Cells.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0121707
- By:
- Publication type:
- Article
Identification of the role of bone morphogenetic protein (BMP) and transforming growth factor-β (TGF-β) signaling in the trajectory of serotonergic differentiation in a rapid assay in mouse embryonic stem cells in vitro.
- Published in:
- Journal of Neurochemistry, 2015, v. 132, n. 4, p. 418, doi. 10.1111/jnc.12999
- By:
- Publication type:
- Article
Protein kinase cAMP-dependent regulatory type II beta ( PRKAR2B) gene variants in antipsychotic-induced weight gain.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2014, v. 29, n. 4, p. 330, doi. 10.1002/hup.2407
- By:
- Publication type:
- Article
Clozapine Acts as an Agonist at Serotonin 2A Receptors to Counter MK-801-Induced Behaviors through a βArrestin2-Independent Activation of Akt.
- Published in:
- Neuropsychopharmacology, 2014, v. 39, n. 8, p. 1902, doi. 10.1038/npp.2014.38
- By:
- Publication type:
- Article
A Hypothesis-Driven Association Study of 28 Nuclear-Encoded Mitochondrial Genes with Antipsychotic-Induced Weight Gain in Schizophrenia.
- Published in:
- Neuropsychopharmacology, 2014, v. 39, n. 6, p. 1347, doi. 10.1038/npp.2013.312
- By:
- Publication type:
- Article
Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5- HT)<sub>2A</sub> and DA D<sub>2</sub> antagonism and 5- HT<sub>1A</sub> partial agonism.
- Published in:
- Journal of Neurochemistry, 2014, v. 128, n. 6, p. 938, doi. 10.1111/jnc.12512
- By:
- Publication type:
- Article
Fat Mass- and Obesity-Associated (FTO) Gene and Antipsychotic-Induced Weight Gain: An Association Study.
- Published in:
- Neuropsychobiology, 2014, v. 69, n. 1, p. 59, doi. 10.1159/000356231
- By:
- Publication type:
- Article
Refractory Psychosis: Treatment Options and Strategies.
- Published in:
- 2014
- By:
- Publication type:
- Lesson Plan
Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype--targeted drugs.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 12, p. 4986, doi. 10.1172/JCI70678
- By:
- Publication type:
- Article
Translating the N-methyl-d-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.
- Published in:
- International Journal of Neuropsychopharmacology, 2013, v. 16, n. 10, p. 2181, doi. 10.1017/S1461145713000928
- By:
- Publication type:
- Article
Augmentation of antipsychotic drug action by azapirone 5-HT1A receptor partial agonists: a meta-analysis.
- Published in:
- International Journal of Neuropsychopharmacology, 2013, v. 16, n. 6, p. 1259, doi. 10.1017/S1461145713000151
- By:
- Publication type:
- Article
Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2013, v. 28, n. 2, p. 183, doi. 10.1002/hup.2288
- By:
- Publication type:
- Article
Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study.
- Published in:
- Journal of Psychopharmacology, 2012, v. 26, n. 9, p. 1201, doi. 10.1177/0269881111430748
- By:
- Publication type:
- Article
Prevention of the Phencyclidine-Induced Impairment in Novel Object Recognition in Female Rats by Co-Administration of Lurasidone or Tandospirone, a 5-HT<sub>1A</sub> Partial Agonist.
- Published in:
- Neuropsychopharmacology, 2012, v. 37, n. 10, p. 2175, doi. 10.1038/npp.2012.64
- By:
- Publication type:
- Article
Association study of GRIK1 gene polymorphisms in schizophrenia: case-control and family-based studies.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2012, v. 27, n. 4, p. 345, doi. 10.1002/hup.2233
- By:
- Publication type:
- Article
Genetic interactions in the adrenergic system genes: analysis of antipsychotic-induced weight gain.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2011, v. 26, n. 6, p. 386, doi. 10.1002/hup.1219
- By:
- Publication type:
- Article
Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspective.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2011, v. 26, n. 1, p. 21, doi. 10.1002/hup.1161
- By:
- Publication type:
- Article
Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2010, v. 25, n. 7/8, p. 582, doi. 10.1002/hup.1146
- By:
- Publication type:
- Article
Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes.
- Published in:
- International Journal of Neuropsychopharmacology, 2010, v. 13, n. 6, p. 793, doi. 10.1017/S1461145710000167
- By:
- Publication type:
- Article
Glial cell line-derived neurotrophic factor receptor alpha 2 (GFRA2) gene is associated with tardive dyskinesia.
- Published in:
- Psychopharmacology, 2010, v. 210, n. 3, p. 347, doi. 10.1007/s00213-010-1829-4
- By:
- Publication type:
- Article
A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia.
- Published in:
- Neuropsychopharmacology, 2010, v. 35, n. 6, p. 1315, doi. 10.1038/npp.2009.235
- By:
- Publication type:
- Article
Association study of polymorphisms in Insulin Induced Gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2010, v. 25, n. 3, p. 253, doi. 10.1002/hup.1111
- By:
- Publication type:
- Article
Pimavanserin, a Serotonin<sub>2A</sub> Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis.
- Published in:
- Neuropsychopharmacology, 2010, v. 35, n. 4, p. 881, doi. 10.1038/npp.2009.176
- By:
- Publication type:
- Article
Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjects.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2009, v. 24, n. 8, p. 676, doi. 10.1002/hup.1076
- By:
- Publication type:
- Article
Asenapine.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Amisulpride is a potent 5-HT<sub>7</sub> antagonist: relevance for antidepressant actions in vivo.
- Published in:
- Psychopharmacology, 2009, v. 205, n. 1, p. 119, doi. 10.1007/s00213-009-1521-8
- By:
- Publication type:
- Article
Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2009, v. 24, n. 5, p. 415, doi. 10.1002/hup.1036
- By:
- Publication type:
- Article
Asenapine Increases Dopamine, Norepinephrine, and Acetylcholine Efflux in the Rat Medial Prefrontal Cortex and Hippocampus.
- Published in:
- Neuropsychopharmacology, 2008, v. 33, n. 12, p. 2934, doi. 10.1038/npp.2008.20
- By:
- Publication type:
- Article
Oakley Ray, 1931–2007.
- Published in:
- Neuropsychopharmacology, 2008, v. 33, n. 11, p. 2783, doi. 10.1038/sj.npp.1301676
- By:
- Publication type:
- Article